Liver metastases: Analysis of survival and the value of systematic chemotherapy in adenocarcinomas
Metástasis hepáticas: Análisis de la sobrevida y del valor de la Quimioterapia sistemática en los adenocarcinomas
Resumen:
The authors study the incidence of hepatic metastasis in a series of 1049 patients bearing tumors of different histopathology; centering the analysis on digestive and genital adenocarcinomas .In this group th e incidence reached 29 'lo. The longest mean survival time was found in ovary tumors: 12.7 months; and the shortest mean survival time was found in pancreatic tumors: 2 months. The authors analyze the therapeutical effect of the systemic chemotherapy admirristered, which seems to lengthen the survival time, however without a statistical significance. Finally the authors speak about the need for a clinical stratification of these patients in order to give a better treatment orientation and to mark the general therapy guidelines.
Se estudia la incidencia de metástasis hepáticas en un total de 1049 enfermos portadores de tumores de diferente histopatología, centrando el análisis sobre los adenocarcinomas digestivos y genitales. En este grupo la incidencia alcanzó el 29%. La sobrevida promedio más prolongada correspondió a los tumores ováricos: 12. 7 meses y la mas corta a los pancreáticos: 2 meses. Se hacen consideraciones sobre la acción terapéutica de la quimioterapia sistémica administrada, la que parece prolongar la sobrevida, aunque sin alcanzar real significación estadística. Finalmente se postula la necesidad de la estratificación clínica de este tipo de pacientes para mejor orientar los tratamientos, y también se marcanguías terapéuticas generales.
1982 | |
metástasis hepáticas tumores adenocarcinomas tratamiento liver metastases tumors adenocarcinomas treatment |
|
Español | |
Sociedad de Cirugía del Uruguay | |
Revista Cirugía del Uruguay | |
https://revista.scu.org.uy/index.php/cir_urug/article/view/3570 | |
Acceso abierto |
Sumario: | The authors study the incidence of hepatic metastasis in a series of 1049 patients bearing tumors of different histopathology; centering the analysis on digestive and genital adenocarcinomas .In this group th e incidence reached 29 'lo. The longest mean survival time was found in ovary tumors: 12.7 months; and the shortest mean survival time was found in pancreatic tumors: 2 months. The authors analyze the therapeutical effect of the systemic chemotherapy admirristered, which seems to lengthen the survival time, however without a statistical significance. Finally the authors speak about the need for a clinical stratification of these patients in order to give a better treatment orientation and to mark the general therapy guidelines. |
---|